BioSpace News Archive

Johnson & Johnson (NYSE: JNJ) today issued the following statement regarding speculation about the safety of our products.

Biotechnology Innovation Organization, President & CEO James C. Greenwood issued a statement on the Hatch-Waxman Integrity Act of 2018

It is no secret that poor patient adherence to medical regimens leads to frequent re-hospitalizations, poor disease outcomes and increased health care costs.

Honourable Ginette Petitpas Taylor, federal Minister of Health, the Honourable Larry Bagnell, Member of Parliament, and the Honourable Pauline Frost, Minister of Health and Social Services, Yukon, will announce new measures to increase access to treatment for substance use disorder.

Herbalife Nutrition, presented a $30,000 donation to the YWCA’s Best Choice Center in Winston-Salem to help replace a damaged roof.

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, and SIRION Biotech GmbH today announced the entry into a license agreement, pursuant to which Orchard has licensed SIRION’s LentiBOOST™

Neem Biotech, a company focused on developing novel solutions to address antimicrobial resistance, together with the Welsh Wound Innovation Centre and Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB) announced today the receipt of a £50,000 inaugural National Biofilms Innovation Centre (NBIC) Proof of Concept grant

Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorization for ZIRABEV

Women’s Care Florida is pleased to announce that Helen M. Kuroki, MD, has been named as the company’s chief medical officer. She succeeds Donald Wilson, MD, who is retiring on January 4, 2019.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teladoc Health, Inc.